Novartis Articles
Alcon to build drug plant in Singapore
21 April 2008
Strong Ph II CAPS data for Novartis' ACZ885
14 April 2008
Stock Commentary - Europe - week to April 7, 2008
14 April 2008
Japanese drug firms adapting for growth
14 April 2008
Pfizer launches free Sutent program in Nepal
14 April 2008
India NGOs at war with cancer drug patents
7 April 2008
Stock Commentary - Europe - week to Mach 31, 2008
7 April 2008
UK's NICE to finalize approval of Lucentis
7 April 2008
Mylan seeks more generic market share
7 April 2008
Stock Commentary - Europe - week to March 24, 2008
31 March 2008
Stock Commentary - Europe - week to March 17, 2008
24 March 2008
HalcyGen's SUBA-Itraconazole in commercial production
24 March 2008
SMC OKs Cubicin for MRSA indications
17 March 2008
Femara cuts risk of breast cancer returning
17 March 2008
Speedel's 2007 loss down 19.2% on sales
17 March 2008
Stock Commentary - Europe - week to March 3, 2008
10 March 2008
NicOx' FY 2007 income doubles, big year ahead
10 March 2008
Everolimus trial halted after early PFS gains
10 March 2008
Four Actavis generics gets US FDA approval
3 March 2008
Elderly urged to change lifestyle to battle AMD
3 March 2008
Novartis' Eucreas cleared in EU
3 March 2008
Foreign groups try to stop Thailand CL climbdown
3 March 2008
AstraZeneca to appeal $215M Ala damages
3 March 2008
Alex Gorsky leaves Novartis to join J&J's Ethicon
25 February 2008
Doctors claim statins cause memory loss
25 February 2008
Stock Commentary - Europe - week to Feb 11, 2008
18 February 2008
Thailand Health Ministry change could mean fewer CLs
18 February 2008
Stock Commentary - Europe - week to Feb 4, 2008
11 February 2008
EMEA clears Galvus labeling update
11 February 2008
Japan drug approval recommendations
11 February 2008
Stock Commentary - Europe - week to Jan 28, 2008
4 February 2008
US physician survey finds big differences in Rx patterns between cardiologists and PCPs
4 February 2008
Orion/Novartis' Stalevo fares well in Ph III trial
4 February 2008
Novartis' Tekturna HCT cleared by FDA
28 January 2008
Novartis to boost Spanish Diovan production
28 January 2008
Stock Commentary - Europe - week to Jan 21, 2008
28 January 2008
Synosia completes proof-of-concept rufinamide trial
28 January 2008
Japan stock market week to Jan 21, 2008
28 January 2008
"NICE blight" means UK patients could miss out on new drugs"
28 January 2008
Generic settlements over Exelon and Imitrex
28 January 2008
Enrollment "well on track" for Ph III TLT trial
28 January 2008
"Switch" drugs next frontier in Japan
28 January 2008
Wales' drug authority recommends Sprycel
28 January 2008
UPDATE: Raids on major drugmakers as EU Commission starts pharma sector inquiry with unannounced inspections
21 January 2008
Stock Commentary - Europe - week to Jan 14, 2008
21 January 2008
Novartis closes Japan research unit
21 January 2008
Meta-analysis in The Lancet recommends statins for all diabetics, regardless of CV risk
21 January 2008
German drug price fixing penalties
21 January 2008
FDA warns: severe pain with bisphosphonates
14 January 2008
US new drug approvals hit 24-year low
14 January 2008
Actelion becomes full member of Swiss Interpharma
14 January 2008
Myfortic cuts GI effects in transplant recipients
14 January 2008
Stock Commentary - Europe - week to January 7, 2008
7 January 2008
Sanofi-Aventis defers 2,600 medical rep job cuts
7 January 2008
Novartis UK cuts deal with the NICE for clinical trial design
24 December 2007
Correction: Novartis' Galvus
24 December 2007
UCB raises guidance for 2008 above consensus
24 December 2007
UPDATE: EMEA to withdraw lumiracoxib approval
24 December 2007
Galvus gets positive opinion from CHMP
24 December 2007
Barr unit sues Watson and Sandoz over Seasonale patent
24 December 2007
EMEA to withdraw lumiracoxib approval
24 December 2007
India's drugmakers apply for IP protection
24 December 2007
Novartis announces a further 2,500 job cuts
17 December 2007
Novartis extends Nanobodies accord with Ablynx
17 December 2007
New Rxing info for carbamazepine agreed
17 December 2007
Stock Commentary - Europe - week to Dec 10, 2007
17 December 2007
Exjade cuts high iron levels in b-thalassemia
17 December 2007
3rd-qtr global pharmaceutical R&D pipeline report from Fitch
17 December 2007
UK NICE set for U-turn on Lucentis
17 December 2007
Novartis plans cutbacks to reduce red tape
17 December 2007
UPDATE: MedImmune's biologics capabilities to boost AstraZeneca's flagging pipeline
17 December 2007
Speedel eligible for royalties from Novartis
10 December 2007
Stock Commentary - Europe - week to Dec 3, 2007
10 December 2007
Sanofi invests $25.4M in Goa R&D center
10 December 2007
Novartis signs 10-year Ab drug R&D alliance with MorphoSys potentially worth up to $1.0B
10 December 2007
Raft of pending patent expiries threaten cardiovascular blockbusters
10 December 2007
Almirall's COPD drug aclidinium bromide is a potential jewel in the company's crown
10 December 2007
Octreotide implant sees 6-month efficacy
10 December 2007
FDA panel recommends warning on salmeterol
10 December 2007
NICE recommends Novartis' Xolair
3 December 2007
Beijing Med-Pharm to market Enablex in China
3 December 2007
Novartis clarifies Brazil investment plan
3 December 2007
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
